• Breaking News

    DMD: Single CRISPR treatment provides long-term benefits in mice

    Researchers have shown that a single systemic treatment using CRISPR genome editing technology can safely and stably correct a genetic disease -- Duchenne muscular dystrophy (DMD) -- for more than a year in mice, despite observed immune responses and alternative gene editing outcomes.

    from Latest Science News -- ScienceDaily http://bit.ly/2GNjyVn

    No comments

    Post Top Ad


    Post Bottom Ad